Skip to main content
# العنوان المشارك في البحث سنة البحث
11 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters د. آمن حمدى زكى على 2025
12 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients د. صلاح مبروك خلاف عبدربه 2025
13 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line أماني محمد عبدالمعتمد محمد 2024
14 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer د. حنان احمد محمد احمد 2024
15 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line د. صلاح مبروك خلاف عبدربه 2024
16 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line د. شيماء حسن شعبان حسن 2024
17 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer د. عادل جمعه محمد جبر 2024
18 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line د. آمن حمدى زكى على 2024
19 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer هدير محمد سعد الشاذلي 2024
20 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line أ.د.أشرف زيدان عبدالله أحمد 2024